BetterLife Pharma Correlations
| BETRF Stock | USD 0.08 0.01 9.59% |
The current 90-days correlation between BetterLife Pharma and Living Cell Technologies is 0.03 (i.e., Significant diversification). The correlation of BetterLife Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
BetterLife Pharma Correlation With Market
Significant diversification
The correlation between BetterLife Pharma and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding BetterLife Pharma and DJI in the same portfolio, assuming nothing else is changed.
BetterLife |
The ability to find closely correlated positions to BetterLife Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BetterLife Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BetterLife Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BetterLife Pharma to buy it.
Moving together with BetterLife OTC Stock
| 0.67 | NVO | Novo Nordisk AS | PairCorr |
| 0.66 | NONOF | Novo Nordisk AS | PairCorr |
| 0.68 | CSLLY | CSL | PairCorr |
| 0.65 | CMXHF | CSL Limited | PairCorr |
| 0.76 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.65 | QSAM | Qsam Biosciences | PairCorr |
| 0.65 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.74 | KO | Coca Cola Fiscal Year End 11th of February 2025 | PairCorr |
| 0.75 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Moving against BetterLife OTC Stock
| 0.79 | AVTE | Aerovate Therapeutics | PairCorr |
| 0.72 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.65 | HNRC | Houston Natural Resources | PairCorr |
| 0.6 | GOOG | Alphabet Class C Aggressive Push | PairCorr |
| 0.47 | SLF | Sun Life Financial | PairCorr |
| 0.76 | CSCO | Cisco Systems | PairCorr |
| 0.73 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
| 0.69 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.65 | T | ATT Inc Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.64 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.62 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.61 | DIS | Walt Disney | PairCorr |
| 0.6 | PYPL | PayPal Holdings Aggressive Push | PairCorr |
| 0.58 | WMT | Walmart | PairCorr |
| 0.37 | HD | Home Depot | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between BetterLife OTC Stock performing well and BetterLife Pharma OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BetterLife Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SBHMY | 0.62 | 0.19 | 0.00 | 0.99 | 0.00 | 0.00 | 25.86 | |||
| DTCFF | 0.75 | 0.09 | 0.00 | (0.22) | 0.00 | 0.00 | 25.87 | |||
| ALRN | 4.44 | (0.23) | 0.00 | (0.34) | 0.00 | 9.81 | 41.47 | |||
| ENLV | 3.42 | (0.36) | 0.00 | (0.53) | 0.00 | 9.03 | 26.52 | |||
| LVCLF | 1.99 | (0.47) | 0.00 | (0.38) | 0.00 | 0.00 | 66.02 | |||
| MCET | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| HESG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| MYMX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| MRZM | 9.04 | 2.04 | 0.05 | (0.42) | 10.21 | 33.33 | 128.57 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in BetterLife Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
BetterLife Pharma Corporate Management
Elected by the shareholders, the BetterLife Pharma's board of directors comprises two types of representatives: BetterLife Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BetterLife. The board's role is to monitor BetterLife Pharma's management team and ensure that shareholders' interests are well served. BetterLife Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BetterLife Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anthony Calandra | Head Regulatory | Profile | |
| Ahmad Doroudian | CEO Founder | Profile | |
| Abdi Ghaffari | Head Toxicology | Profile | |
| Scott Rudge | Head CMC | Profile | |
| Hooshmand Sheshbaradaran | Chief Officer | Profile |